Article info

Download PDFPDF

Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples

Authors

  1. Correspondence to Dr Bernard Combe, Département de Rhumatologie, Hôpital Lapeyronie, Montpellier 34295, France; b-combe{at}chu-montpellier.fr
View Full Text

Citation

Combe B, van Vollenhoven R
Novel targeted therapies: the future of rheumatoid arthritis? Mavrilumab and tabalumab as examples

Publication history

  • Accepted April 8, 2013
  • First published April 26, 2013.
Online issue publication 
August 06, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.